Global Amyotrophic Lateral Sclerosis Treatment Market Share

Statistics for the 2023 & 2024 Global Amyotrophic Lateral Sclerosis Treatment market share, created by Mordor Intelligence™ Industry Reports. Global Amyotrophic Lateral Sclerosis Treatment share report includes a market forecast to 2030 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Amyotrophic Lateral Sclerosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Overview

The amyotrophic lateral sclerosis treatment market is slightly fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some companies are Mitsubishi Tanabe Pharma Corporation, Sun Pharmaceutical Industries Ltd., CORESTEM, Inc, BrainStorm Cell Limited, Amylyx Pharmaceuticals Inc., AB Science, Ionis Pharmaceuticals, Biohaven Pharmaceutical, Biogen, and F.Hoffmann-La Roche AG.

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Leaders

  1. Mitsubishi Tanabe Pharma Corporation

  2. CORESTEM, Inc

  3. BrainStorm Cell Limited

  4. Amylyx Pharmaceuticals Inc.

  5. Biogen

  6. *Disclaimer: Major Players sorted in no particular order
Amyotrophic Lateral Sclerosis Treatment Market Concentration

Global Amyotrophic Lateral Sclerosis Treatment Market Report Snapshots